24.12.2012 Views

Healthcare and Distribution Services - Audon Trap & Partners

Healthcare and Distribution Services - Audon Trap & Partners

Healthcare and Distribution Services - Audon Trap & Partners

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

<strong>Healthcare</strong> <strong>and</strong> <strong>Distribution</strong> <strong>Services</strong><br />

Sudco of Multipharma Flex Pharma Advisor to buyer<br />

Holl<strong>and</strong> Corporate Finance advised Flex Pharma on the acquisition of Sudco, a<br />

producer of OTC products.<br />

Flex Pharma is a producer of pharmaceuticals, vitamin supplements <strong>and</strong> dermocosmetics.<br />

Sudco was part of Multipharma. Multipharma is a subsidiary of Novartis<br />

(www.novartis.com), a pharmaceutical multinational which is engaged in the<br />

research, development, manufacture <strong>and</strong> marketing of medicines.<br />

Symare Pharma Tramedico International Advisor to buyer<br />

/ Flex Pharma<br />

Holl<strong>and</strong> Corporate Finance advised Tramedico International (www.tramedico.nl) <strong>and</strong><br />

the joint venture on the formation of the joint venture Symare Pharma.<br />

Tramedico International focuses on the marketing, sales <strong>and</strong> distribution of<br />

medicines <strong>and</strong> self-care products in the Benelux. Flex Pharma is a producer of<br />

pharmaceuticals, vitamin supplements <strong>and</strong> dermo-cosmetics.<br />

M&A International Inc.<br />

member firm:<br />

SteriGenics International, Inc. Ion Beam Applications s.a. Advisor to seller TM Capital Corp.<br />

SteriGenics International, Inc. (NASDAQ: STER) is a leading provider of contract<br />

irradiation <strong>and</strong> sterilization services for health care <strong>and</strong> other markets.<br />

TM Capital assisted SteriGenics in completing three strategic acquisitions which<br />

brought the company into new geographic markets, new sterilization technologies<br />

<strong>and</strong> new market applications.<br />

TM Capital then assisted SteriGenics in completing its $214 million sale to Ion Beam<br />

Applications s.a. (BB: IBAB), a leading provider of particle accelerators for health<br />

care <strong>and</strong> other markets. TM Capital also provided a fairness opinion in connection<br />

with the sale of SteriGenics to IBA.<br />

Holl<strong>and</strong> Corporate Finance<br />

Holl<strong>and</strong> Corporate Finance<br />

30

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!